Author details

Full Name

Elisabetta Patorno

Affiliation

Harvard Medical School

ORCID

Career Start Year

2006

Papers

165

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37876341	Stratified analysis in comparative effectiveness studies that emulate randomized trials.	Pharmacoepidemiol Drug Saf	2024
38079178	Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy.	JAMA Intern Med	2024
37853843	High-Dose vs. Standard-Dose Influenza Vaccine and Cardiopulmonary Hospitalization or Mortality: Emulating the INVESTED Trial Using Insurance Claims Data.	Clin Pharmacol Ther	2024
37985010	Successful implementation of a stakeholder engagement program for pharmacoepidemiologic research.	Pharmacoepidemiol Drug Saf	2024
36383481	Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure.	Diabetes Care	2023
37938032	Real-World Continuous EEG Utilization and Outcomes in Hospitalized Patients With Acute Cerebrovascular Diseases.	J Clin Neurophysiol	2023
37677118	Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes.	Diabetes Care	2023
37461243	Achieving comparability in glycemic control between antidiabetic treatment strategies in pregnancy when using real world data.	Pharmacoepidemiol Drug Saf	2023
37354026	Common non-cardiovascular multimorbidity groupings and clinical outcomes in older adults with major cardiovascular disease.	J Am Geriatr Soc	2023
37259575	Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.	Eur Heart J	2023
37345734	Frailty and uptake of angiotensin receptor neprilysin inhibitor for heart failure with reduced ejection fraction.	J Am Geriatr Soc	2023
37342987	Prognostic Factors of COVID-19: An Umbrella Review Endorsed by the International Society for Pharmacoepidemiology.	Clin Pharmacol Ther	2023
37339346	Use of Real-World Data in Population Science to Improve the Prevention and Care of Diabetes-Related Outcomes.	Diabetes Care	2023
37037982	Continuous Glucose Monitoring in Adults with Diabetes in Clinical Practice: Increased Access and Education Needed.	J Gen Intern Med	2023
37097356	Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.	JAMA	2023
37395339	Contemporary trends in the utilization of second-line pharmacological therapies for type 2 diabetes in the United States and the United Kingdom.	Diabetes Obes Metab	2023
37195239	Safety of SGLT2i with regard to bone and mineral metabolism in patients with CKD.	Curr Opin Nephrol Hypertens	2023
36745425	Comparing Effectiveness and Safety of SGLT2 Inhibitors vs DPP-4 Inhibitors in Patients With Type 2 Diabetes and Varying Baseline HbA1c Levels.	JAMA Intern Med	2023
36608816	Empagliflozin cardiovascular and renal effectiveness and safety compared to dipeptidyl peptidase-4 inhibitors across 11 countries in Europe and Asia: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.	Diabetes Metab	2023
36866496	Risk of Severe Hypoglycemia With Newer Second-line Glucose-lowering Medications in Older Adults With Type 2 Diabetes Stratified by Known Indicators of Hypoglycemia Risk.	J Gerontol A Biol Sci Med Sci	2023
36827225	Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study.	Clin J Am Soc Nephrol	2023
36938914	Antidiabetes medication initiation trends in US adults with cirrhosis and type 2 diabetes: A nationwide study.	Diabetes Obes Metab	2023
33298465	Framework for the synthesis of non-randomised studies and randomised controlled trials: a guidance on conducting a systematic review and meta-analysis for healthcare decision making.	BMJ Evid Based Med	2022
35470055	Risk of Hospitalization for Heart Failure in Patients With Hyperkalemia Treated With Sodium Zirconium Cyclosilicate Versus Patiromer.	J Card Fail	2022
35729705	Machine learning for improving high-dimensional proxy confounder adjustment in healthcare database studies: An overview of the current literature.	Pharmacoepidemiol Drug Saf	2022
35605236	Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.	Ann Intern Med	2022
35597823	Pradhan et al. Respond to "Large-Scale, Multisite Studies Using Real-World Data".	Am J Epidemiol	2022
35713732	Anti-seizure medication treatment and outcomes in acute ischemic stroke patients undergoing continuous EEG monitoring.	Neurol Sci	2022
35777664	Cardiovascular and Mortality Risk with Intravitreal Vascular Endothelial Growth Factor Inhibitors in Patients with Diabetic Retinopathy.	Ophthalmol Retina	2022
36150454	Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.	Am Heart J	2022
36170656	Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.	Diabetes Care	2022
36264574	Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.	JAMA Netw Open	2022
36167266	Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.	Diabetes Res Clin Pract	2022
36219443	Association of Sodium-Glucose Cotransporter-2 Inhibitors With Incident Atrial Fibrillation in Older Adults With Type 2 Diabetes.	JAMA Netw Open	2022
34985178	Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes.	Pharmacoepidemiol Drug Saf	2022
34953068	The use of glucose-lowering medications for the treatment of type 2 diabetes mellitus during pregnancy in the United States.	Endocrinol Diabetes Metab	2022
35043165	Three Sides to the Story: Adherence Trajectories During the First Year of SGLT2 Inhibitor Therapy Among Medicare Beneficiaries.	Diabetes Care	2022
35038405	Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.	Ann Intern Med	2022
35038404	Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.	Ann Intern Med	2022
34908211	Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.	Pharmacoepidemiol Drug Saf	2022
35136902	Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study.	Am J Epidemiol	2022
35321742	Association of SGLT2 inhibitors with cardiovascular, kidney, and safety outcomes among patients with diabetic kidney disease: a meta-analysis.	Cardiovasc Diabetol	2022
34762974	SGLT2 Inhibitors and the Risk of Acute Kidney Injury in Older Adults With Type 2 Diabetes.	Am J Kidney Dis	2022
34843082	Antiseizure Medication Treatment and Outcomes in Patients with Subarachnoid Hemorrhage Undergoing Continuous EEG Monitoring.	Neurocrit Care	2022
34750282	Linking the Paul Coverdell National Acute Stroke Program to commercial claims to establish a framework for real-world longitudinal stroke research.	Stroke Vasc Neurol	2022
34260087	Prevalence of Avoidable and Bias-Inflicting Methodological Pitfalls in Real-World Studies of Medication Safety and Effectiveness.	Clin Pharmacol Ther	2022
34256144	Glucagon-Like Peptide-1 Receptor Agonists and Hepatic Decompensation Events in Patients With Cirrhosis and Diabetes.	Clin Gastroenterol Hepatol	2022
33127370	Epidemiologic Characterization of Heart Failure with Reduced or Preserved Ejection Fraction Populations Identified Using Medicare Claims.	Am J Med	2021
33495295	Comparative Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Versus Glucagon-Like Peptide 1 Receptor Agonists in Older Adults.	Diabetes Care	2021
33651454	Prescribing trends and clinical characteristics of patients starting antiobesity drugs in the United States.	Diabetes Obes Metab	2021

1 - 50 of 165

Erica A Voss

Erasmus University Medical Center

Career Start Year 2014

Number of shared co-authors 0

Lana Y H Lai

The University of Manchester, University of Manchester

Career Start Year 2013

Number of shared co-authors 1

Julia M Akeroyd

Section of Health Services Research, Baylor College of Medicine

Career Start Year 2013

Number of shared co-authors 0

Hemalkumar B Mehta

Johns Hopkins Bloomberg School of Public Health

Career Start Year 2012

Number of shared co-authors 4

Ruijun Chen

USA Tempus Labs Inc.

Career Start Year 2012

Number of shared co-authors 0

Frank DeFalco

Janssen Pharmaceutical Research & Development

Career Start Year 2011

Number of shared co-authors 2

Phillip J Schulte

Division of Clinical Trials and Biostatistics, Mayo Clinic

Career Start Year 2011

Number of shared co-authors 1

Patrick B Ryan

Columbia University Irving Medical Center

Career Start Year 2010

Number of shared co-authors 8

Rohan Khera

Yale School of Medicine

Career Start Year 2009

Number of shared co-authors 0

James S Floyd

Cardiovascular Health Research Unit, University of Washington

Career Start Year 2008

Number of shared co-authors 4

Sengwee Toh

Harvard Medical School and Harvard Pilgrim Health Care Institute

Career Start Year 2006

Number of shared co-authors 12

Ann Marie Navar

UT Southwestern Medical Center

Career Start Year 2006

Number of shared co-authors 1

Christianne L Roumie

Vanderbilt University Medical Center

Career Start Year 2004

Number of shared co-authors 1

Robert A Greevy

Vanderbilt University Medical Center

Career Start Year 2004

Number of shared co-authors 0

Mulugeta Gebregziabher

Ralph H. Johnson Veterans Affairs Healthcare System.

Career Start Year 2004

Number of shared co-authors 0

Michele Jonsson Funk

University of North Carolina at Chapel Hill

Career Start Year 2002

Number of shared co-authors 3

Nilay D Shah

Mayo Clinic

Career Start Year 2002

Number of shared co-authors 0

Mikhail Kosiborod

Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City

Career Start Year 2001

Number of shared co-authors 1

Soko Setoguchi

Rutgers University Institute for Health, the State University of New Jersey

Career Start Year 2001

Number of shared co-authors 5

Eric McArthur

Lawson Health Research Institute

Career Start Year 1999

Number of shared co-authors 0

Lesley H Curtis

Duke Clinical Research Institute

Career Start Year 1999

Number of shared co-authors 6

Joseph S Ross

Yale School of Medicine

Career Start Year 1999

Number of shared co-authors 2

Mark J Pletcher

University of California-San Francisco

Career Start Year 1998

Number of shared co-authors 0

Matthew A Weir

Western University

Career Start Year 1996

Number of shared co-authors 0

David J Ramsey

Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine

Career Start Year 1993

Number of shared co-authors 0

Todd A MacKenzie

Geisel School of Medicine at Dartmouth

Career Start Year 1992

Number of shared co-authors 0

Michael Matheny

American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School

Career Start Year 1991

Number of shared co-authors 9

Muhammad Mamdani

Institute of Health Policy, University of Toronto

Career Start Year 1984

Number of shared co-authors 2

Joel N Swerdel

Janssen Research & Development LLC

Career Start Year 1982

Number of shared co-authors 0

Alan S Go

Kaiser Permanente Northern California

Career Start Year 1962

Number of shared co-authors 5

row(s) 1 - 30 of 30

Sebastian Schneeweiss

Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School

Co-authored papers 57

Rishi J Desai

Harvard Medical School

Co-authored papers 33

Shirley V Wang

Brigham and Women's Hospital, Harvard Medical School

Co-authored papers 11

Joshua J Gagne

Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital

Co-authored papers 11

Michael Fralick

University of Toronto

Co-authored papers 10

Yoonyoung Park

Moderna Inc.

Co-authored papers 7

Seanna Vine

Co-authored papers 6

Christine Y Lu

Harvard Medical School and the Harvard Pilgrim Health Care Institute

Co-authored papers 4

Michael B Westover

Beth Israel Deaconess Medical Center

Co-authored papers 4

Aaron S Kesselheim

Brigham and Women's Hospital.

Co-authored papers 4

Sahar F Zafar

Massachusetts General Hospital

Co-authored papers 3

Gianluca TrifirÃ²

Co-authored papers 3

Judith C Maro

Harvard Pilgrim Health Care Institute and Harvard Medical School

Co-authored papers 2

Miriam C J M Sturkenboom

University Medical Center Utrecht

Co-authored papers 2

Sebastien Haneuse

Harvard T.H. Chan School of Public Health

Co-authored papers 2

Eric S Rosenthal

Beth Israel Deaconess Medical Center, Division of Neurocritical Care and Emergency Neurology, Division of Clinical Neurophysiology, Massachusetts General Hospital, Boston, MA, Harvard Medical School, Massachusetts General Hospital, Massachusetts General Hospital Fellowship in Epilepsy and Clinical Neurophysiology, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School Fellowship Training Program in Neurocritical Care, Massachusetts General Hospital, Brigham and Women's Hospital, Harvard Medical School Partners Neurology Residency Training Program, Yale College

Co-authored papers 2

Michael Nguyen

Center for Drug Evaluation and Research

Co-authored papers 2

Paula R Sanches

Hospital Israelita Albert Einstein

Co-authored papers 2

Hang Lee

Massachusetts General Hospital

Co-authored papers 2

John Hsu

Mongan Institute, Massachusetts General Hospital and Harvard Medical School